Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




When Should Men Be Tested for Osteoporosis?

By HospiMedica staff writers
Posted on 21 Aug 2003
Male osteoporosis is more common than most people believe, with men over 50 being at greater risk of osteoporosis-related fracture than they are for prostate cancer. More...
Until the prevalence of male osteoporosis is better known, however, bone-density screening for men 50 and under is not currently recommended.

While the causes of male osteoporosis are not yet well understood, the greatest risk is in men who have a parent with osteoporosis, have kidney stones, have pituitary problems, or have been treated with glucocorticoids. Men who have kidney stones are at high risk. Secondary risk factors are alcohol, smoking, and malnourishment. Among Caucasian men 65 and older, about 80% of hip fractures will be attributed to osteoporosis. Mortality in men one year after a hip fracture is nearly twice as high as it is for women.

Men over 50 who complain of unexplained back pain or other secondary causes, such as a history of kidney stones, alcoholism, and steroids usage, should be screened with bone density testing. Men over 55 should also be screened who have inexplicably lost two or more inches in height or have sustained a fracture during adult life. After diagnosis, underlying factors such as diet and the intake of calcium and vitamin D should be improved.

This update on male osteoporosis was presented at the annual meeting of the American Association of Clinical Chemistry in Philadelphia (PA, USA) by Clifford J. Rosen, M.D., affiliated with St. Joseph Hospital (Bangor, ME, USA) and director of the Maine Center for Osteoporosis Research and Education.




Related Links:
St. Joseph Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.